This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1978 Jun;8(4):412-3.

doi: 10.1007/BF01968660.

M F Cuthbert et al. Agents Actions. 1978 Jun.

. 1978 Jun;8(4):412-3.

doi: 10.1007/BF01968660.

No abstract available

Post-marketing surveillance of adverse reactions to new medicines.
Wilson AB. Wilson AB. Br Med J. 1977 Oct 15;2(6093):1001-3. doi: 10.1136/bmj.2.6093.1001. Br Med J. 1977. PMID: 922357 Free PMC article. No abstract available.
Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
Cahal DA. Cahal DA. Can Med Assoc J. 1968 Feb 10;98(6):271-5. Can Med Assoc J. 1968. PMID: 5636096 Free PMC article. No abstract available.
Present attitudes of governmental drug regulatory agencies.
Noel PR. Noel PR. Int J Clin Pharmacol. 1973 Apr;7(2):168-77. Int J Clin Pharmacol. 1973. PMID: 4731283 No abstract available.
Drug hepatotoxicity from a regulatory perspective.
Senior JR. Senior JR. Clin Liver Dis. 2007 Aug;11(3):507-24, vi. doi: 10.1016/j.cld.2007.06.002. Clin Liver Dis. 2007. PMID: 17723917 Review.
[Reactions and interactions of drugs. Safety measures from Drug Safety Committee of the United Kingdom].
D'Arcy PF. D'Arcy PF. J Pharm Belg. 1999 Mar-Apr;54(2):44-7. J Pharm Belg. 1999. PMID: 10380410 Review. French. No abstract available.